ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "risk assessment"

  • Abstract Number: 1612 • ACR Convergence 2021

    Factors Associated with COVID-19 Vaccine Hesitancy Among Individuals with Rheumatic Disease

    Kristin Wipfler1, Adam Cornish1, Alison Freifeld2, Patricia Katz3 and Kaleb Michaud2, 1FORWARD, The National Databank for Rheumatic Diseases, Omaha, NE, 2University of Nebraska Medical Center, Omaha, NE, 3University of California San Francisco, San Francisco, CA

    Background/Purpose: COVID-19 vaccination efforts are ongoing and there is a need to understand factors associated with vaccine hesitancy. Individuals with rheumatic diseases have been uniquely…
  • Abstract Number: 0091 • ACR Convergence 2021

    Vaccination of Patients with Chronic Inflammatory Rheumatic Diseases: An Analysis of Barriers and Facilitators in a Prospective Cohort

    Ioana Andreica, Iulia Roman, Xenofon Baraliakos, Juergen Braun and Uta Kiltz, Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany

    Background/Purpose: Patients (pts.) with chronic inflammatory rheumatic diseases (CIRD) are often not adequately protected against infectious diseases. As shown in an earlier study, less than…
  • Abstract Number: 1662 • ACR Convergence 2021

    Unrecognised, Subclinical, Structural or Functional Lung Changes in Rheumatoid Arthritis Is Associated with a Higher Risk of Developing Serious Respiratory Tract Infection

    Benjamin Worcester1, Dorothy Wang2, Susan Morton3 and Michelle Leech4, 1Monash Health, Melbourne, Australia, 2Melbourne Health, Clayton, Australia, 3Monash Health, Clayton, Australia, 4Monash Medical Centre, Australia, Australia

    Background/Purpose: The incidence of lung disease within the rheumatoid arthritis is well described and likely underestimated. Additionally, RA patients are at higher risk for developing…
  • Abstract Number: 0236 • ACR Convergence 2021

    Maternal Attachment, Anxiety and Depressive Symptoms in Pregnant Women with Rheumatic Diseases

    Luis Gerardo Espinosa-Banuelos1, Diana Carolina Rubio Torres2, Maria Corral2, Cassandra Skinner Taylor2, Lorena Perez-Barbosa2, Luz Fernanda Gutierrez Leal2, Abraham Yair Lujano-Negrete3, Jesus Cardenas-de La Garza2 and Dionicio Galarza-Delgado2, 1Faculty of Medicine and University Hospital Dr. Jose Eleuterio Gonzalez, UANL, Monterrey, Mexico, 2Hospital Universitario "Dr Jose E. Gonzalez", Monterrey, Mexico, 3Hospital Universitario Dr. José Eleuterio González, Monterrey, Mexico

    Background/Purpose: Untreated perinatal anxiety symptomatology can be related to symptoms of anxiety and depression during the postpartum. The psychological bond created by the mother between…
  • Abstract Number: 1006 • ACR Convergence 2020

    Post-menopausal Rheumatoid Arthritis Is Inversely Associated with Lifetime High Level of Estrogen Exposure in the French E3N Cohort

    Carine Salliot1, Yann Nguyen2, Amandine Gelot3, Xavier Mariette4, Marie-Christine Boutron-Ruault3 and Raphaèle Seror5, 1CHR orleans, Orleans, France, 21Department of Internal Medicine, Hôpital Beaujon, APHP Nord, Université de Paris, Clichy, Clichy, France, 3Institut Gustave Roussy, Villejuif, France, 4Paris-Sud University, Rueil-Malmaison, France, 5Rheumatology Department, Bicetre Hospital, APHP, France, Paris, France

    Background/Purpose: The involvement of female hormones in the pathogenesis of Rheumatoid Arthritis (RA) is supported by numerous observations: a female predominance, an increased incidence in…
  • Abstract Number: 1021 • ACR Convergence 2020

    Organ Damage in Systemic Lupus Erythematosus Is Attributable More to Comorbidity (Hypertension) and Less to Socioeconomic Status

    Romy Kallas1, Jessica Li2, Daniel Goldman3 and Michelle Petri3, 1Johns Hopkins Medical Institution, Baltimore, MD, 2Johns Hopkins University, Baltimore, MD, 3Johns Hopkins University School of Medicine, Timonium, MD

    Background/Purpose: Multiple variables are known to contribute to development of organ damage in SLE patients, including prednisone use and ethnicity. The aim of this study…
  • Abstract Number: 1066 • ACR Convergence 2020

    Prevalence of Cervical Dysplasia in Women with Antisynthetase Syndrome

    Alexis Katz1, Yuxuan Jin1 and Soumya Chatterjee2, 1Cleveland Clinic, Cleveland, OH, 2Cleveland Clinic, Richmond Heights, OH

    Background/Purpose: Increased risk of cervical dysplasia and cervical cancer have been reported in patients with systemic lupus erythematosus (SLE). However, the reason for this increased…
  • Abstract Number: 1149 • ACR Convergence 2020

    Risk Score of Macrophage Activation Syndrome (MAS) in Patients with Systemic Juvenile Idiopathic Arthritis (sJIA)

    Simone Carbogno1, Denise Pires Marafon2, Giulia Marucci2, Emanuela Sacco2, Manuela Pardeo2, Alhanouf Alsaleem3, Sarka Fingerhutova4, Ferhat Demir5, Nastasia Cekada6, Mikhail Kostik7, Christoph Kessel8, Olga Vougiouka9, Alenka Gagro10, Jessica Tibaldi11, Francesca Minoia12, Ilaria Maccora13, Rayfel Schneider14, Pavla Dolezalova15, Betul Sozeri16, Marija Jelusic6, Antonella Insalaco2, Fabrizio De Benedetti17 and Claudia Bracaglia2, 1Pediatric Area, University of Milan, Milan, Italy, 2Division of Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, Rome, Italy, 3Division of Pediatric Rheumatology, Department of pediatrics, King Faisal specialist hospital and research center, Riyadh, Saudi Arabia, RiYADH, Saudi Arabia, 4Rheumatology Unit, Department of Paediatrics and Adolescent Medicine, Charles University in Prague, Dlouha 534, Kladno, 27201, Czech Republic, 5University of Health Sciences, Umraniye Tranining and Research Hospital Division of Pediatric Rheumatology, Istanbul, Turkey, Istanbul, Turkey, 6University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia, Zagreb, Grad Zagreb, Croatia, 7Saint-Petersburg State Pediatric Medical University, Saint-Petersburg, Russia, Sto arrivando!, Russia, 8Department of Pediatric Rheumatology and Immunology, University Hospital Muenster, Muenster, Germany, Muenster, Germany, 9Second Department of Paediatrics, P. & A. Kyriakou Children’s Hospital, Athens, Greece, Athens, Greece, 10Children's Hospital Zagreb, Josip Juraj Strossmayer University of Osijek, Medical Faculty Osijek, Zagreb, Croatia, Zagreb, Grad Zagreb, Croatia, 11UOC Clinica Pediatrica e Reumatologia, IRCCS Istituto Giannina Gaslini, Genoa, Italy, Genoa, Italy, 12Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy, Milan, Italy, 13Paediatric Rheumatology Unit, Anna Meyer Children's University Hospital, School of Human Health Science, Florence, Italy, Florence, Italy, 14University of Toronto, The Hospital for Sick Children, Toronto, Canada, 15Paediatric Rheumatology and Autoinflammatory Diseases Unit, General University Hospital, Prague, Czech Republic, Prague, Czech Republic, 16University of Health Sciences, Umraniye Tranining and Research Hospital Division of Pediatric Rheumatology Istanbul, Turkey, Istanbul, Turkey, 17Division of Rheumatology, Laboratory of Immuno-Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, Rome, Italy

    Background/Purpose: Macrophage Activation Syndrome (MAS) is a severe, life-threatening, complication of Systemic Juvenile Idiopathic Arthritis (sJIA) with a significant mortality. A score that identify sJIA…
  • Abstract Number: 1174 • ACR Convergence 2020

    HEADSS and Shoulders, Knees and Toes: Improving Sexual Orientation and Gender Identity Screening in the Pediatric Rheumatology Clinic

    Nayimisha Balmuri1, Jacob Spitznagle1, Alexa Adams1, Karen Onel2, Sarah Taber1 and Nancy Pan1, 1Hospital for Special Surgery, new york, NY, 2Pediatric Rheumatology, Hospital for Special Surgery, New York, NY

    Background/Purpose: Adolescence is an especially vulnerable time when many rheumatologic conditions first present for diagnosis and management. Adolescence brings unique challenges including those relating to…
  • Abstract Number: 1187 • ACR Convergence 2020

    Red Cell Distribution Width Is Associated with ASCVD Risk Score and CVD in RA After Initiation of Methotrexate

    Ibtissam Gad1, Sofi Damjanovska2, Lenche Kostadinova3, Alyssa Lange4, Christopher Burant4, Brigid Wilson5, Taissa Bej5, Nora Singer6, Maya Mattar7, David Zidar8 and Donald Anthony9, 1Case Western Reserve/ Cleveland VA Medical Center, Cleveland Heights, OH, 2Case Western Reserve University/Cleveland VA Medical Center, Cleveland Heights, OH, 3(1) Department of Medicine, VA Medical Center and VA GRECC, Case Western Reserve University, Cleveland OH, Highland Heights, OH, 4Case Western Reserve University, Cleveland, 5Department of Medicine, VA Medical Center and VA GRECC, Case Western Reserve University, Cleveland OH, Cleveland, 6The MetroHealth System, Case Western Reserve University School of Medicine, Cleveland, OH, 7Department of Medicine, VA Medical Center and VA GRECC, Case Western Reserve University, Cleveland OH, Cleveland, OH, 8Case Western Reserve University/Cleveland VA Medical Center, Cleveland, 9Case Western Reserve University/Cleveland VA Medical Center/MetroHealth Medical Center, Cleveland, OH

    Background/Purpose: Rheumatoid arthritis (RA) has been shown to be associated with increased risk of cardiovascular disease (CVD)  and mortality. Red cell distribution width (RDW) represents…
  • Abstract Number: 1193 • ACR Convergence 2020

    Unsupervised Molecular Profile Clustering in the Serum of Rheumatoid Arthritis Patients Identifies Groups with Differential CV-risk SCORE: Modulation by Biological Therapies

    Maria Luque-Tevar1, Carlos Pérez-Sánchez1, Pilar Font2, Alejandra Maria Patiño-Trives1, Montserrat Romero-Gomez2, Desirée Ruiz-Vilchez2, Sara Remuzgo-Martínez3, Raquel López-Mejías4, Iván Arias de la Rosa1, Carmen Torres-Granados1, María-Carmen Abalos-Aguilera1, Rafaela Ortega-Castro2, Alejandro Escudero-Contreras2, Carlos Rodriguez-Escalera5, Jose Perez-Venegas6, Mª Dolores Ruiz-Montesinos6, Carmen Dominguez6, Carmen Romero-Barco7, Antonio Fernandez-Nebro8, Natalia Mena-Vazquez9, Jose Luis Marenco10, Julia Uceda-Montañez10, Mª Dolores Toledo-Coello11, Nuria Barbarroja1, M Angeles Aguirre2, Eduardo Collantes2, Miguel A Gonzalez-Gay12 and Chary Lopez-Pedrera1, 1Rheumatology Department, Reina Sofia University Hospital/ Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ University of Cordoba, Cordoba, Spain, Cordoba, Spain, 2Rheumatology Department, Reina Sofia University Hospital/ Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ University of Cordoba, Cordoba, Spain, Córdoba, Spain, 3Research group on genetic epidemiology and atherosclerosis in systemic diseases and in metabolic bone diseases of the musculoskeletal system, IDIVAL, Santander, Spain, 4Research group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic bone Diseases of the Musculoskeletal System, IDIVAL, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain, 5Hospital Universitario de Jaen, Jaén, Spain, 6Hospital Universitario Virgen Macarena, Sevilla, Sevilla, Spain, 7Hospital Clínico Universitario, Málaga, Málaga, Spain, 8University of Malaga, Malaga, Spain, 9Hospital Regional Universitario de Málaga, Málaga, Spain, 10Hospital Universitario Virgen de Valme, Sevilla, Sevilla, Spain, 11Hospital Universitario de Jerez de la Frontera, Cádiz, Spain, Cádiz, Spain, 12Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander

    Background/Purpose: To identify specific molecular profiles associated to the enhanced cardiovascular (CV)-risk present in Rheumatoid Arthritis (RA) patients and their modulation by biologic disease modifying…
  • Abstract Number: 1286 • ACR Convergence 2020

    Personalizing Cardiovascular Risk Prediction for Patients with Systemic Lupus Erythematosus by Physician Global Assessment of Disease Activity

    May Choi1, Emma Stevens2, Hongshu Guan2, Daniel Li3, Jack Ellrodt4, Benjamin Kargere4, Tianrun Cai2, Kazuki Yoshida5, Brendan Everett2 and Karen Costenbader6, 1Brigham and Women's Hospital | Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 2Brigham and Women's Hospital, Boston, MA, 3Harvard, Columbus, OH, 4Williams College, Williamstown, 5Brigham & Women's Hospital and Harvard Medical School, Boston, MA, 6Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: The risk of cardiovascular disease (CVD), including myocardial infarction and stroke, is higher in SLE than in the general population. The excess risk of…
  • Abstract Number: 1328 • ACR Convergence 2020

    Cardiac Biomarkers Are Associated with the Development of Cardiovascular Events in Patients with Psoriatic Arthritis and Psoriasis

    Keith Colaco1, Ker-Ai Lee2, Shadi Akhtari3, Raz Winer4, Paul Welsh5, Naveed Sattar5, Iain McInnes6, Vinod Chandran7, Paula Harvey8, Richard Cook2, Dafna Gladman7, Vincent Piguet8 and Lihi Eder9, 1Institute of Medical Science, University of Toronto; Women's College Research Institute, Women's College Hospital; and Toronto Western Hospital, University Health Network, Toronto, ON, Canada, 2University of Waterloo, Waterloo, ON, Canada, 3Women's College Hospital, University of Toronto, North York, ON, Canada, 4Rambam Health Care Campus, Haifa, Israel, 5University of Glasgow, Glasgow, Scotland, United Kingdom, 6Institute of Infection, Immunity, and Inflammation, University of Glasgow, Glasgow, United Kingdom, 7Krembil Research Institute, Toronto Western Hospital, Toronto, ON, Canada, 8Women's College Hospital, University of Toronto, Toronto, ON, Canada, 9Women’s College Research Institute, University of Toronto, Toronto, ON, Canada

    Background/Purpose: N-terminal pro-brain-type natriuretic peptide (NT-proBNP) and troponin I (TnI) are established cardiac biomarkers that predict cardiovascular events (CVEs) and mortality in apparently healthy individuals…
  • Abstract Number: 1475 • ACR Convergence 2020

    Predictors of Thirty-Day Hospital Readmissions in Systemic Lupus Erythematosus in the US: A Nationwide Study

    Rayan Najjar1, Swetha Ann Alexander2, Grant Hughes1, Jinoos Yazdany3 and Namrata Singh4, 1University of Washington, Seattle, WA, 2University of Connecticut, Hartford, CT, 3UCSF, San Francisco, CA, 4University of Washington, Bellevue, WA

    Background/Purpose: For individuals with systemic lupus erythematosus (SLE), hospital readmission rate is associated with quality of care and prognosis. Our objective was to evaluate independent…
  • Abstract Number: 0181 • ACR Convergence 2020

    Methotrexate Use Does Not Increase the Prevalence of Hepatic Steatosis: A Real-World Retrospective Nested Case-Control Study

    Yunjung Choi1, Chang-Hun Lee1, Myeung-Su Lee2, Chang-Hoon Lee2, SoJeong Park3 and Wan-Hee Yoo4, 1Jeonbuk National University Hospital, Jeonju, Republic of Korea, 2Wonkwang University Hospital, Iksan, Republic of Korea, 3Data Science Team, Hanmi Pharm. Co., Ltd, Seoul, Romania, 4Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Republic of Korea

    Background/Purpose: We aimed to determine whether methotrexate (MTX) treatment in patients with rheumatoid arthritis (RA) leads to the development of nonalcoholic fatty liver (NAFL).Methods: Data…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology